Last update 08 May 2025

Bendroflumethiazide/Potassium Chloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Centyl K
Target
NCC
Action
inhibitors
Mechanism
NCC inhibitors(Thiazide-sensitive sodium-chloride cotransporter inhibitors)
Therapeutic Areas
Cardiovascular DiseasesUrogenital DiseasesOther Diseases
Active Indication
EdemaHypertensionNephrolithiasis
Inactive Indication-
Originator Organization
Karo Healthcare ABKaro Healthcare AB
Active Organization
Karo Healthcare ABKaro Healthcare AB
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
Sweden (17 Sep 2010),
EdemaHypertensionNephrolithiasis
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaClK
InChIKeyWCUXLLCKKVVCTQ-UHFFFAOYSA-M
CAS Registry7447-40-7
View All Structures (2)

Related

1
Clinical Trials associated with Bendroflumethiazide/Potassium Chloride
DRKS00004564
/ RecruitingNot ApplicableIIT
Influence of Hippotherapy-K on adults with Cerebral Palsy on the functional parameters during walking and stair climbing - Hippo-K-CP
100 Clinical Results associated with Bendroflumethiazide/Potassium Chloride
Login to view more data
100 Translational Medicine associated with Bendroflumethiazide/Potassium Chloride
Login to view more data
100 Patents (Medical) associated with Bendroflumethiazide/Potassium Chloride
Login to view more data
100 Deals associated with Bendroflumethiazide/Potassium Chloride
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Edema
Sweden
Karo Healthcare ABKaro Healthcare AB
17 Sep 2010
Hypertension
Sweden
Karo Healthcare ABKaro Healthcare AB
17 Sep 2010
Nephrolithiasis
Sweden
Karo Healthcare ABKaro Healthcare AB
17 Sep 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free